Effectiveness of a Combined Aloe Vera-Peppermint Gel on Prevention Pressure Injuries Among Intensive Care Unit Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAli Abd-Alredha Hussein

About this trial

The goal of this clinical trails is to learn if a combined Aloe Vera-Peppermint gel work to prevent pressure injuries (bedsores) in ICU patients.

Does applying this natural gel reduce the incidence of pressure injuries compared to standard care?

participants will be randomly assigned to either receive the gel application (Aloe Vera-Peppermint gel) or the standard hospital nursing care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ICU patients aged 18 years or older.

Admission to the ICU without pressure injury according to the NPUAP scale on the first day of hospitalization.

Unconsciousness, being under sedation or assisted ventilation.

Patients that are at risk of moderate to severe PIs according to Braden scoring tool and scored less than 13-14.

Disqualifiers

Family's unwillingness for the patient to continue participation

Sensitivity to Aloe Vera-Peppermint Gel after use on a patient's forearm (area of 2 × 2 cm) and this area was evaluated for the presence of redness, swelling and warmth within 45 min.

Spinal cord injury cases

death or patient transmission in less than 48 hrs. after admission to the ICU.

Trial design

Design model

Parallel

Treatments tested in this trial

  • combined Aloe Vera-Peppermint gel

    Combination product

    Topical gel containing a combination of natural Aloe vera extract and peppermint oil. The intervention involves applying a thin layer of the gel to pressure-prone areas such as the sacrum and heels to prevent the development of pressure injuries. The application is performed twice daily during the patient's stay in the ICU.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: experimental groupExperimental treatment 1 intervention
Group B: control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

incidence of pressure injuries

The number of participants who develop any new pressure injury during their ICU stay. Pressure injuries include Stage I, Stage II, Stage III, Stage IV, Unstageable, and Deep Tissue Pressure Injury, as defined by the National Pressure Injury Advisory Panel (NPIAP). Assessment will be performed daily by trained nursing staff using the Braden Scale and comprehensive clinical skin examination of pressure-prone areas.

Time frame
From the date of ICU admission until 10 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ali Abd-Alredha Hussein

Lead sponsor

University of Baghdad

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: